Evidence map›Paper›PMID 36102668›Full record

ReviewClinical & experimental ophthalmology2022

Ophthalmic imaging in diabetic retinopathy: A review.

Onnisa Nanegrungsunk, Direk Patikulsila, Srinivas R Sadda

Abstract readReview
In one paragraph

Review in Clinical & experimental ophthalmology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Onnisa NanegrungsunkDoheny Imaging Reading Center, Doheny Eye Institute, Pasadena, California, USA.ORCID 0000-0001-9542-1323
Direk PatikulsilaRetina Division, Department of Ophthalmology, Chiang Mai University, Chiang Mai, Thailand.
Srinivas R SaddaDoheny Imaging Reading Center, Doheny Eye Institute, Pasadena, California, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Retinal imaging has been a key tool in the diagnosis, evaluation, management and documentation of diabetic retinopathy (DR) and diabetic macular oedema (DMO) for many decades. Imaging technologies have rapidly evolved over the last few decades, yielding images with higher resolution and contrast with less time, effort and invasiveness. While many retinal imaging technologies provide detailed insight into retinal structure such as colour reflectance photography and optical coherence tomography (OCT), others such as fluorescein or OCT angiography and oximetry provide dynamic and functional information. Many other novel imaging technologies are in development and are poised to further enhance our evaluation of patients with DR.

Indexed as

Diabetes MellitusDiabetic RetinopathyMacular EdemaFluorescein AngiographyHumansPhotographyRetinaTomography, Optical Coherencediabetic eye diseasediabetic macular oedemadiabetic retinopathyfundus imageocular imaging

Identifiers

PMID36102668
PMCPMC10088017

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.